Clinical trial

Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC

NCT01767779

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-09-01

PhaseN/A

Study timeline

Study start (unknown)2012-09-01Date precision: month

Registry last updated2019-04-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberous Sclerosis Complexunresolved

Interventions

Sponsors & collaborators

University of Alabama at Birminghamlead sponsor

Children's Hospital Medical Center, Cincinnaticollaborator

The University of Texas Health Science Center, Houstoncollaborator

University of California, Los Angelescollaborator

Boston Children's Hospitalcollaborator

Mapped research locations

HoustonTexas, United States1 BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 BirminghamAlabama, United States1 CincinnatiOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01767779 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.